no image available Dickens & Co. "Double the Impact: Harnessing the Power of Combined IGF1R and MEK Blockade for KRAS-Mutant Lung Cancer Therapy" "Unleashing the Potential of a Novel Two-Pronged Approach to Tackle the Aggressive Disease" Price: 34.00€